Latest News Archive
Please select Category, Year, and then Month to display items
07 January 2018
Photo Charl Devenish
Dr Anneke van der Spoel van Dijk is invested in contributing
to the global effort of stopping TB by 2035.
The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB).
She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB).
Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.
Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”
Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”
As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.
Prestigious Fulbright Scholarship to Senior Researcher
2010-05-27
 |
| Ms Melody Mentz. |
Ms Melody Mentz, Ph.D. student and Senior Researcher at the University of the Free State’s (UFS) Division for Student Development and Success (SDS) has been awarded the prestigious Fulbright Scholarship award to work on her Ph.D. in the United States of America (USA). This award has only been granted to a limited number of students from the UFS in the past.
For the 12-month duration of the scholarship, Ms Mentz will be based at Indiana University in Bloomington, Indiana. During this time she will be doing a part-time internship at the National Survey of Student Engagement (NSSE) Institute. Ms Mentz will also be completing doctoral level coursework in the School of Education’s Higher Education and Student Affairs programme. She intends to complete her Ph.D. thesis during her time abroad.
Both her Ph.D. and research work at SDS focus on factors influencing the success of students in South African higher education and the impact of student engagement on student success. More specifically, her Ph.D. focuses on how high-school experiences and expectations of higher education influence the success of first-year students at the UFS.
Ms Mentz completed her B.Com (Human Resource Management), as well as the rest of her postgraduate studies in Psychology at the UFS, obtaining all her qualifications with distinction. She was also the recipient of the Dean’s medal for the best honours student in the Faculty of Economic and Management Sciences in 2006, and the Kovsie Dux student of the year in 2005.
Ms Mentz will be departing for the USA during August of 2010.